Gore snags FDA approval for components; Life, Illumina back genomics in the field;

 @FierceMedDev: Experts: Odds of device tax repeal close to zero. Item | Follow @FierceMedDev

@MarkHFierce: Covidien begins postapproval study for stroke treatment device. More | Follow @MarkHFierce

 @DamianFierce: Last thing from JPM13: Talking Chinese outsourcing with Vertex, Merck, MedImmune and WuXi. Story | Follow @DamianFierce

> Gore snagged FDA approval for three components that give its Excluder AAA Endoprosthesis more sizing options for wide-ranging patients. News

> Hologic ($HOLX) picked up 510(k) clearance for its Aptima Trichomonas vaginalis Assay, a women's-health test now OK'ed for use with the company's Panther diagnostic platform. More

> Phoenix Cardiac Devices has launched clinical trials in India and Europe designed to get a CE mark for Bace, the company's device that works to keep blood flowing the right direction in the mitral valve. Release

> Parallax Diagnostics is now Endeavor Sciences, and parent company Endeavor Power ($EDVP) is moving the company to Cambridge, MA. Item

> Both Illumina ($ILMN) and Life Technologies ($LIFE) are backing startups that support clinical genomics. Article

> Critical Diagnostics has joined the Healthcare Accreditation Colloquium, an organization that unites heart failure experts in hospitals, and will integrate its Presage ST2 heart diagnostic into the group's care model. Story

Biotech News

 @FierceBiotech: Trending on FierceBiotech.com: $GSK pilots 6th drug to regulators in R&D offensive. More | Follow @FierceBiotech

@JohnCFierce: Activists cry havoc, let slip the dogs of war on AstraZeneca. News | Follow @JohnCFierce

@RyanMFierce: PatientsLikeMe tackles extremely rare genetic disease. Item | Follow @RyanMFierce

> Vanderbilt scores another neuroscience drug pact as AstraZeneca signs on. More

> Eisai's pivotal hopes for ovarian cancer drug dashed by PhIII flop. Story

> Aileron snags $12M to fuel first human study of 'stapled' peptide. Article

Pharma News

@FiercePharma: Zytiga wins European approval for earlier use. FDA did the same in December. Could be big for Janssen/J&J. More | Follow @FiercePharma

 @AlisonBFierce: Widespread flu outbreak gives vaccine manufacturers a shot in the arm. News | Follow @AlisonBFierce

> Generic Reglan user can sue Pfizer for damages. Article

> Brand-new AbbVie reveals second Synthroid recall. News

> India to hit Roche, BMS with compulsory licenses on 3 cancer drugs. Story

Biotech IT News

> How 'open' will Big Pharma get to treat R&D ills? Item

> Computer game rewards players for shirking flu shots. Report

> Elsevier snaps up drug R&D software company. Article

> Illumina, Life Tech trumpet startup efforts in clinical genomics. News

CRO News

> Report: Indian drug-related trial deaths rose in 2012. Report

> goBalto inks deal with INC for trial software. Article

> Catalent breathes $20M into inhalant business. News

> GVK partners with Onconova on cancer drugs. Story

> Parexel chief named ACRO chairman. Item

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.